Skip to Main Content

INFORMATION FOR

    Lingeng Lu, MD, PhD

    Research Scientist in Epidemiology (Chronic Diseases)
    DownloadHi-Res Photo

    Contact Info

    Chronic Disease Epidemiology

    PO Box 208034, 60 College Street

    New Haven, CT 06520-8034

    United States

    About

    Titles

    Research Scientist in Epidemiology (Chronic Diseases)

    Biography

    Dr. Lu is currently a Research Scientist in the Department of Chronic Disease Epidemiology at the Yale School of Public Health. Dr. Lu’s research focuses on determining the role of genetic, epigenetic and environmental factors in the susceptibility and clinical outcome of chronic diseases, particularly human cancer (gynecologic and gastrointestinal cancer), metabolic syndrome, HIV/ADIS, mental and reproductive health. He is now leading the Molecular Cancer Epidemiology Laboratory and Shared Resource of the Yale Cancer Center and YSPH, and develops molecular biology tools and technologies, providing critical laboratory supports for studies by colleagues. His research also involves data mining, bioinformatics and pathway analyses, DNA/RNA secondary structure. Using next-generation small RNA-seq technologies, he recently explored the associations of miRNAs in circulating cell-secreted exosomes and HIV-associated neurological disorders. His research has addressed the prognostic and predictive values of genetic, epigenetic (non-coding RNAs and DNA methylation), growth factors and immunological factors in several human malignancies, and the effect of the biological and environmental factors on the risk of several chronic diseases.

    Appointments

    Education & Training

    Postdoctoral Associate
    Yale University School of Medicine (2008)
    PhD
    Texas A & M University (2004)
    MS
    Shanghai Medical University, Epidemiology (1999)
    MD
    Shanghai Medical University (1991)

    Research

    Overview

    1. Genetic, epigenetic and environmental factors in cancer risk and progression

    As a chronic disease, human cancer has a complex etiology, resulting from the comprehensive consequence of genetic, epigenetic and environmental factors. Genetic and epigenetic aberrations frequently occur in malignancies. In this project, we aim to evaluate the significance of genetic variations, gene expression and non-coding RNA (miRNAs and lncRNAs) and DNA methylation, RNA methylation-associated genes, cancer stem cell-associated genes and environmental factors, as well as their interactions in cancer etiology, diagnosis and prognosis using population-based case-control studies (endometrial, liver, bladder, brain, gastric, esophageal, pancreatic cancer) and case cohort studies. We also investigate the mechanisms of functional variants via the approaches such as DNA/RNA secondary structures, eQTL and pQTL. The long-term goal is to individualize prevention and treatment of human cancer.

    2. Circulating exosomes and HIV-associated neurological disorders and cancer

    Exosomes are bilayer membranous nano-vesicles actively released into the circulation by living cells, and contain enriched bioactive molecules (proteins, DNA/RNA, lipids), mirroring the cells of origin and mediating cell-to-cell communications in a hormone manner. We aim to investigate the associations of exosomal bioactive molecules in plasma (non-coding RNAs and proteins) and HIV-associated neurological disorders (in collaboration with Dr. Spudich at Neurobiology and Dr. Emu at Infectious Diseases), and the risk of cancer. The long-term goals are to develop novel strategies to prevent neurological impairment of HIV patients during antiretroviral therapy (ART) for the HIV project, and to early detect human cancer, and to monitor the disease progression via liquid biopsy.

    3. Exercise and healthy living in breast cancer and ovarian cancer survivors

    Exercise and healthy eating are beneficial effects on human health. We aim to investigate the effects of exercise and healthy lifestyles intervention on the risk factors and immunosuppression of breast and ovarian cancer in the survivors. The long-term goal is to prevent the cancers and reduce the mortality by modifying lifestyles.

    4. Immune checkpoints and cancer progression

    Immune escaping is a hallmark of tumors. Immune responses in tumors depend on neoantigen presentation, T cell infiltration and effector T cell activation. We aim to examine the associations between microenvironmental factors, immune checkpoints and T cell activation, and tumor progression. The long-term goal is to develop novel strategies to individualize immunotherapy.

    5. Telomere, aging and cancer

    Telomeres are the repeat sequences at the end of chromosomes for genome stability and integrity, and get shorter each time a cell divides. When telomere length reaches a critical threshold, the cell enters senescence and stops growth. Telomere lengthening machinery maintains the telomere length in malignancies, allowing an limited cellular lifespan. We aim to understand how environmental factors and lifestyles affect telomere length, how telomere machinery associates with aging and cancer progression and treatment.



    Medical Research Interests

    Aging; Breast Neoplasms; DNA Methylation; Endometrial Neoplasms; Helicobacter pylori; HIV; Immunologic Factors; Insulin-Like Growth Factor II; Metabolic Syndrome; MicroRNAs; Molecular Epidemiology; Ovarian Neoplasms; Pancreatic Neoplasms; Polymorphism, Genetic; Reproductive Medicine; RNA, Long Noncoding

    Public Health Interests

    Cancer; Genetics, Genomics, Epigenetics

    Research at a Glance

    Yale Co-Authors

    Frequent collaborators of Lingeng Lu's published research.

    Publications

    2024

    2023

    Clinical Trials

    Current Trials

    Academic Achievements & Community Involvement

    • activity

      Clinical Epigenetics

    • activity

      World Journal of Microbiology and Biotechnology

    • activity

      Scientific Reports

    • activity

      American Association of Cancer Research

    • activity

      American Association for the Advancement of Science

    Get In Touch

    Contacts

    Academic Office Number
    Mailing Address

    Chronic Disease Epidemiology

    PO Box 208034, 60 College Street

    New Haven, CT 06520-8034

    United States

    Supported Faculty

    Locations

    • 60 College Street

      Academic Office

      Ste 706

      New Haven, CT 06510